DNMT1 and obesity disorder: It has been reported that pharmacological inhibition of PPARγ1 promoter DNA methylation via 5-aza-2′-deoxycytidine or genetically by DNMT1 knockout promotes macrophage alternative activation in obesity (Wang et al., 2016).